EU Bolar exemption is not so simple
The EU directive to introduce a US-style Bolar provision promised to harmonise the law on clinical trials. But, says Marina Barnden, inconsistent application has led to uncertainty
The EU Bolar provision was introduced by an amendment in 2004 to the Directive on the Community Code Relating to Medicinal Products for Human Use 2001/83/EC (the Medicinal Code). As patent law largely remains within the prerogative of EU member...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.